Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)

Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority (BARDA). AIGIV, which was acquired in the Cangene acquisition completed earlier this year, is being developed as an intravenous therapeutic treatment for inhalation … Continue reading Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)